Fetal Bovine Serum (Prime, Uruguay/Brazil)

Fetal Bovine Serum (Prime, Uruguay/Brazil)

Catalog Number:
MAR1388671EXC
Mfr. No.:
FSP500; FSP100; FSP050
Price:
$633
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Fetal bovine serum (FBS) is a pale yellow clear liquid separated from fetal bovine blood after coagulation and the removal of fibrinogen and certain coagulation factors from plasma. It is a by-product of the meat processing industry.

          Fetal bovine serum is the largest natural medium used in cell culture, containing abundant nutrients necessary for cell growth, and has extremely important functions. The general addition ratio is 5-20%. Serum contains various amino acids, vitamins, inorganic substances, lipids, and other nutrients necessary for maintaining cell growth. It also contains hormones, growth factors, and binding proteins that can promote cell growth, such as insulin, hydrocortisone, dexamethasone, bFGF, EGF, PDGF, and transferrin. In addition, serum also has detoxification, buffering, and inhibiting protease activity to protect cells from damage.

          Ekosai fetal bovine serum is collected from healthy cattle in non epidemic areas, and is made through aseptic collection, batch mixing, and 3 stage 100 nm filter filtration and sub packaging. It does not contain mycoplasma and bovine viruses such as BVDV, PI3, IBR, and BTV.

          Please contact us at for specific academic pricing.

      • Properties
        • Categories
          Fetal Bovine Serum
          Storage
          -20°C Can be stored for five years

          * For Research Use Only. Not for Diagnostic and Therapeutic Use.

      • Applications
        • Application Description
          Preparation of cell culture-related reagents
          Preparation of blocking solution and diluent in immune reaction
          Development and production of antibodies, viruses, and vaccines
      • Reference
        • Zhong B et al. The Ubiquitin Ligase RNF5Regulates Antiviral Responses by Mediating Degradation of the Adaptor ProteinMITA. Volume 30, ISSUE 3, P397-407, March 20, 2009. Read more(PubMed: 19285439)
          Li Q et al. CRISPR–Cas9-mediatedbase-editing screening in mice identifies DND1 amino acids that are criticalfor primordial germ cell development. Nature cell biology,2018. Read more(PubMed: 30718859)
          Luo YL etal. Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-AssistedPolymeric Nanoparticles. ACS Nano 2018, 12, 994−1005.Read more(PubMed:29314827)
          Du JZ et al. Smart Superstructureswith Ultrahigh pHSensitivity for Targeting Acidic Tumor. ACS Nano 2016, 10,6753−6761.Read more(PubMed:27244096)
          Chen X et al. Long noncoding RNA LBCS inhibits self-renewal andchemoresistance of bladder cancer stem cells through epigenetic silencing ofSOX2. Clinical Cancer Research ,2018. Read more(PubMed:30397178)
          Li HJ et al. Stimuli-responsiveclustered nanoparticles for improved tumor penetration and therapeuticefficacy. PNAS,2018. Read more(PubMed:27035960)
          Li Y et al. ISG56 is anegative-feedback regulator of virus-triggered signaling and cellular antiviral response. PNAS, 2009,106(19): 7945-7950.Read more(PubMed:19416887)
          Wang JL et al. The effect ofsurface poly(ethylene glycol) length on in vivo drug delivery behaviors ofpolymeric nanoparticles. Biomaterials 182(2018)104-113.Read more(PubMed:30114562)

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.